Brown, K. A. & Scherer, P. E. Update on adipose tissue and cancer. Endocr. Rev. 44, 961–974 (2023).
Google Scholar
Kim, S. et al. FAM3C in cancer-associated adipocytes promotes breast cancer cell survival and metastasis. Cancer Res. 84, 545–559 (2024).
Google Scholar
Song, Y. et al. Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation. Nat. Commun. 15, 4052 (2024).
Google Scholar
Rybinska, I. et al. SAA1-dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness. Int. J. Cancer 154, 1842–1856 (2024).
Google Scholar
Zhou, C. et al. Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF/CXCLs positive feedback loop. Int. J. Biol. Sci. 18, 1363–1380 (2022).
Google Scholar
Huang, J. et al. Rhein and hesperidin nanoparticles remodel tumor immune microenvironment by reducing CAFs and CCL2 secreted by CAAs for efficient triple-negative breast cancer therapy. Int. Immunopharmacol. 141, 113001 (2024).
Google Scholar
Takehara, M. et al. Cancer-associated adipocytes promote pancreatic cancer progression through SAA1 expression. Cancer Sci. 111, 2883–2894 (2020).
Google Scholar
Waters, J. A. et al. Omental preadipocytes stimulate matrix remodeling and IGF signaling to support ovarian cancer metastasis. Cancer Res. 84, 2073–2089 (2024).
Google Scholar
Noda, K. et al. Exosomal miR-199a-3p secreted from cancer-associated adipocytes promotes pancreatic cancer progression. Cancer Med. 13, e70265 (2024).
Google Scholar
Bouche, C. & Quail, D. F. Fueling the tumor microenvironment with cancer-associated adipocytes. Cancer Res. 83, 1170–1172 (2023).
Google Scholar
Wei, G. et al. The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy. Cell Metab. 33, 2021–2039.e2028 (2021).
Google Scholar
Huang, R. et al. Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy. Cell Death Dis. 14, 703 (2023).
Google Scholar
Liu, A. et al. Cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy. Adipocyte 11, 487–500 (2022).
Google Scholar
Dong, Y., Bai, J. & Zhou, J. Developing a dormancy-associated ECM signature in TNBC that is linked to immunosuppressive tumor microenvironment and selective sensitivity to MAPK inhibitors. Heliyon 10, e32106 (2024).
Google Scholar
Cai, Z. et al. Cancer‑associated adipocytes exhibit distinct phenotypes and facilitate tumor progression in pancreatic cancer. Oncol. Rep. 42, 2537–2549 (2019).
Google Scholar
Dirat, B. et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 71, 2455–2465 (2011).
Google Scholar
Lee, J. et al. Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism. PLoS One 12, e0174126 (2017).
Google Scholar
Tebbe, C. et al. Metformin limits the adipocyte tumor-promoting effect on ovarian cancer. Oncotarget 5, 4746–4764 (2014).
Google Scholar
Du, L. et al. EPA-enriched phospholipids ameliorate cancer-associated cachexia mainly by inhibiting lipolysis. Food Funct. 6, 3652–3662 (2015).
Google Scholar
Panaroni, C. et al. Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins. Blood 139, 876–888 (2022).
Google Scholar
Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 33, 1001–1012.e1005 (2021).
Google Scholar
Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors. Immunity 54, 1561–1577.e1567 (2021).
Google Scholar
Yang, P. et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat. Commun. 13, 5782 (2022).
Google Scholar
Raajendiran, A. et al. Proteome analysis of human adipocytes identifies depot-specific heterogeneity at metabolic control points. Am. J. Physiol. Endocrinol. Metab. 320, E1068–e1084 (2021).
Google Scholar
Tung, S. et al. PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia. Blood 122, 969–980 (2013).
Google Scholar
Wen, Y. A. et al. Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer. Cell Death Dis. 8, e2593 (2017).
Google Scholar
Kravitz, H. M., Kazlauskaite, R. & Joffe, H. Sleep, health, and metabolism in midlife women and menopause: food for thought. Obstet. Gynecol. Clin. North Am. 45, 679–694 (2018).
Google Scholar
Rask-Andersen, M. et al. Adiposity and sex-specific cancer risk. Cancer Cell 41, 1186–1197.e1184 (2023).
Google Scholar
Chang, C. H., Chang, Y. T., Tseng, T. H. & Wang, C. J. Mulberry leaf extract inhibit hepatocellular carcinoma cell proliferation by depressing IL-6 and TNF-α derived from adipocyte. J. Food Drug Anal. 26, 1024–1032 (2018).
Google Scholar
Frasca, D. et al. Adipocyte-derived inflammatory molecules induce senescent B cells through metabolic pathways. Obesity 32, 1441–1447 (2024).
Google Scholar
Xu, L. L. et al. TNF-α, IL-6, and leptin increase the expression of miR-378, an adipogenesis-related microRNA in human adipocytes. Cell Biochem. Biophys. 70, 771–776 (2014).
Google Scholar
Mantzoros, C. et al. Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab. 89, 1102–1107 (2004).
Google Scholar
Smiechowska, J. et al. Adipokines in patients with cancer anorexia and cachexia. J. Investig. Med. 58, 554–559 (2010).
Google Scholar
Yum, C. et al. 1α,25-Dihydroxyvitamin D downregulates adipocyte impact on breast cancer cell migration and adipokine release. Nutrients 16, (2024).
Iwamoto, H. et al. Cancer lipid metabolism confers antiangiogenic drug resistance. Cell Metab. 28, 104–117.e105 (2018).
Google Scholar
Seki, T. et al. Brown-fat-mediated tumor suppression by cold-altered global metabolism. Nature 608, 421–428 (2022).
Google Scholar
Guo, B. et al. Runx1 activates the transformation of adipocytes into cancer-associated adipocytes by downregulating Plin1. Exp. Cell Res. 448, 114573 (2025).
Google Scholar
Deng, Z. et al. TGF-β signaling in health, disease and therapeutics. Signal Transduct. Target Ther. (2024).
Gao, T. et al. Ovarian cancer-derived TGF-β1 induces CAAs via SMAD3/TRIB3. Cell Death Dis. 15, 930 (2024).
Google Scholar
Yang, Z. et al. Cancer-associated adipocytes in breast cancer: mechanisms and crosstalk. Front. Oncol. 14, (2024).
Gholami, S. et al. Immunoexpression of HIF targets (GLUT1, MCT4, CAIX…). Head. Face Med 19, 8 (2023).
Li, Z. et al. Targeting the lactic-acid metabolic pathway for antitumor therapy. Mol. Ther. Oncolytics. 8, 391 (2023).
Google Scholar
Griffin, M. J. & Ryu, S. Immunometabolic role of NF-κB in adipocytes. Int. J. Mol. Sci. 23, (2022).
Guria, S. et al. Adipose tissue macrophages and their role in obesity. Front. Immunol. 14, 1139152 (2023).
Wu, Q. et al. Immunoregulation in cancer-associated cachexia. J. Adv. Res. 58, 45–62 (2024).
Dong, D. L. et al. YAP and ECM stiffness: key drivers of adipocyte plasticity. Cells 13, 1905 (2024).
Luo, J. et al. New insights into the ambivalent role of YAP/TAZ in human cancers. J. Exp Clin Cancer Res 42, 130 (2023).
Shen, H. et al. Hippo pathway links adipocyte plasticity to adipose fibrosis. Nat. Commun. 13, 6030 (2022).
Guo, B. et al. Runx1 activates transformation of adipocytes into CAAs and promotes breast cancer invasion. Biochem. Biophys. Res. Commun. (2025).
Seo, S. H. et al. C/EBPβ regulates HIF-1α-driven invasion under hypoxia. Antioxidants. 13 (2024).
Lin, Y. C. et al. Adipocytes in PDAC: exosomes/cytokines trigger lipolysis. Cancers 15, 3580 (2023).
Yu, Y. C. et al. KRAS-driven inflammatory cytokines shape the PDAC tumor microenvironment. Front. Oncol. 12, (2022).
Liu, S. Q. et al. Single-cell analysis of white adipose tissue reveals the tumor-promoting adipocyte subtypes. J. Transl. Med. 21, 470 (2023).
Google Scholar
Zhao, G. et al. Single-cell RNA-seq reveals lipid-metabolic rewiring in obese vs nonobese breast tumors. Oncogene (2024).
Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334–1347 (2021).
Google Scholar
Bubnovskaya, L., Ganusevich, I., Merentsev, S. & Osinsky, D. Cancer-associated adipocytes and prognostic value of preoperative neutrophil-lymphocyte ratio in gastric cancer. Exp. Oncol. 45, 88–98 (2023).
Google Scholar
Liu, Y. et al. Tumor-targeted gene therapy with lipid nanoparticles inhibits tumor-associated adipocytes and remodels the immunosuppressive tumor microenvironment in triple-negative breast cancer. Nanoscale Horiz. 6, 319–329 (2021).
Google Scholar
Wolf, M. et al. Histologic characterization of tumor-adjacent mammary adipose tissue in normal-weight and overweight/obese patients with triple-negative breast cancer. Cancers. 16, (2024).
Gao, T. et al. Ovarian cancer-derived TGF-β1 induces cancer-associated adipocytes formation by activating SMAD3/TRIB3 pathway to establish premetastatic niche. Cell Death Dis. 15, 930 (2024).
Google Scholar
Zeng, X. et al. M2 macrophage-derived TGF-β induces age-associated loss of adipogenesis through progenitor cell senescence. Mol. Metab. 84, 101943 (2024).
Google Scholar
Luo, N. et al. Hesperidin PLGA nanoparticles potentiate the efficacy of aPD-1 in treating triple negative breast cancer by regulating CCL2 and ADPN expression in cancer-associated adipocytes. Int. Immunopharmacol. 140, 112759 (2024).
Google Scholar
Permuth, J. B. et al. Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma. Front. Oncol. 14, 362244 (2024).
Google Scholar
Ferrer, M. et al. Cachexia: A systemic consequence of progressive, unresolved disease. Cell 186, 1824–1845 (2023).
Google Scholar
Mariean, C. R., Tiucă, O. M., Mariean, A. & Cotoi, O. S. Cancer Cachexia: New Insights and Future Directions. Cancers. 15, 5590 (2023).
Liu, M. et al. The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia. Cancer Cell 42, 885–903.e884 (2024).
Google Scholar
Poulia, K. A. et al. Pancreatic cancer and cachexia-metabolic mechanisms and novel insights. Nutrients. 12 (2020).
Gandhi, A. Y. et al. Cytokine-mediated STAT3 transcription supports ATGL/CGI-58-dependent adipocyte lipolysis in cancer cachexia. Front. Oncol. 12, 841758 (2022).
Google Scholar
Pan, X. et al. Carnosol analog WK-63 alleviated cancer cachexia by inhibiting NF-κB and activating AKT pathways in muscle while inhibiting NF-κB and AMPK pathways in adipocyte. Toxicol. Appl. Pharm. 479, 116729 (2023).
Google Scholar
Xiong, H. et al. Exosomal EIF5A derived from Lewis lung carcinoma induced adipocyte wasting in cancer cachexia. Cell Signal 112, 110901 (2023).
Google Scholar
Lin, C. N. et al. Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer. J. Biomed. Sci. 31, 62 (2024).
Google Scholar
de Ferranti, S. & Mozaffarian, D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin. Chem. 54, 945–955 (2008).
Google Scholar
Kharroubi, I. et al. Free fatty acids and cytokines induce pancreatic beta-apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145, 5087–5096 (2004).
Google Scholar
Matsuda, M. & Shimomura, I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes. Res. Clin. Pr. 7, e330–e341 (2013).
Google Scholar
Meyer, K. A. et al. Adipocytes promote pancreatic cancer cell proliferation via glutamine transfer. Biochem. Biophys. Rep. 7, 144–149 (2016).
Google Scholar
Zoico, E. et al. Adipocytes WNT5a mediated dedifferentiation: a possible target in pancreatic cancer microenvironment. Oncotarget 7, 20223–20235 (2016).
Google Scholar
Das, S. K. et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 333, 233–238 (2011).
Google Scholar
Jin, J. et al. Design and synthesis of Atglistatin derivatives as adipose triglyceride lipase inhibitors. Chem. Biol. Drug Des. 90, 1122–1133 (2017).
Google Scholar
Kliewer, K. L. et al. Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice. Cancer Biol. Ther. 16, 886–897 (2015).
Google Scholar
Grippo, P. J. et al. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut 61, 1454–1464 (2012).
Google Scholar
Sagar, G. et al. Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut 65, 1165–1174 (2016).
Google Scholar
Gharpure, K. M. et al. FABP4 as a key determinant of metastatic potential of ovarian cancer. Nat. Commun. 9, 2923 (2018).
Google Scholar
Mukherjee, A. et al. Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Res. 80, 1748–1761 (2020).
Google Scholar
Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498–1503 (2011).
Google Scholar
Takakura, T., Shimizu, T. & Yamamoto, N. Antibody‒drug conjugates in solid tumors; new strategy for cancer therapy. Jpn. J. Clin. Oncol. (2024).
Dzierlega, K. et al. Activin A-expressing polymorphonuclear myeloid-derived suppressor cells infiltrate skeletal and cardiac muscle and promote cancer cachexia. J. Immunol. (2023).
Lemecha, M. et al. Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia. Mol. Metab. 66, 101612 (2022).
Google Scholar
Fosch, A. et al. Central regulation of brown fat thermogenesis in response to saturated or unsaturated long-chain fatty acids. Int. J. Mol. Sci. 24, 1697 (2023).
Google Scholar
Luan, Y., You, M., Thompson, T. & Kim, S. Y. Activin A plays a critical role in adipose tissue wasting in the progression of cancer cachexia. J. Endocr. Soc. (2021).
Villodre, E. S. et al. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Mol. Oncol. 15, 2752–2765 (2021).
Google Scholar
Wang, D. et al. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia. J. Hematol. Oncol. 16, 30 (2023).
Google Scholar
Zhang, Z., Zhang, H., Liao, X. & Tsai, H.-I. KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression. Front. Cell Dev. Biol. 11, 1147676 (2023).
Google Scholar
Miki, Y. et al. ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers. J. Endocr. Soc. (2022).
Shen, X., Niu, N. & Xue, J. Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma. J. Transl. Intern. Med., 11, 322–329 (2023).
Schneider, G. & Saur, D. Quo vadis, Kras?. Oncotarget 4, 1336–1337 (2013).
Google Scholar
Riccardi, D. M. D. R. et al. Plasma lipid profile and systemic inflammation in patients with cancer cachexia. Front. Nutr. 7, (2020).
Althaiban, A., Thyagarajan, A. & Sahu, R. P. KRAS pathway-based therapeutic approaches in pancreatic cancer. Mini Rev. Med. Chem. 23, 953–961 (2023).
Google Scholar
Marceca, G. P., Londhe, P. & Calore, F. Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options. Front. Oncol. 10, 298 (2020).
Google Scholar
Webster, J. M., Kempen, L. J. A. P., Hardy, R. S. & Langen, R. C. J. Inflammation and skeletal muscle wasting during cachexia. Front. Physiol. 11, 597675 (2020).
Google Scholar
Morimoto, M., Aikawa, K., Hara, T. & Yamaoka, M. Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models. Oncol. Lett. 14, 8066–8071 (2017).
Google Scholar
Dave, S. & Patel, B. M. Deliberation on debilitating condition of cancer cachexia: Skeletal muscle wasting. Fundam. Clin. Pharmacol. 37, 1079–1091 (2023).
Google Scholar
Miyazaki, M. in Physical Therapy and Research in Patients with Cancer (eds Morishita, S., Inoue, J. & Nakano, J.) 253–274 (Springer Nature Singapore, 2022).
van de Worp, W. R. et al. Nutritional interventions in cancer cachexia: evidence and perspectives from experimental models. Front. Nutr. 7, 601329 (2020).
Google Scholar
Aquila, G. et al. Nutraceuticals and exercise against muscle wasting during cancer cachexia. Cells 9, 2536 (2020).
Google Scholar
Tian, J. Advances in understanding cancer-associated neurogenesis and its implications on the neuroimmune axis in cancer. Pharmacol. Ther. (2022).
Yamamoto, K. et al. Targeting the metabolic rewiring in pancreatic cancer and its tumor microenvironment. Cancers (2022).
Zuzcak, M. & Trnka, J. Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review). Int. J. Oncol. (2022).
Yin, X. et al. Orchestrating intratumoral DC-T-cell immunity for enhanced tumor control via radiotherapy-activated TLR7/8 prodrugs in mice. Nat. Commun. (2025).
Hankir, M. K., Hoffmann, A. & Seyfried, F. Starving cancer into submission by activating BAT. Cell Metab. (2022).
Chen, H. et al. Deciphering the tumor cell-infiltrating landscapes reveal microenvironment subtypes and therapeutic potentials for nonsquamous NSCLC. JCI Insight (2022).
Wang, Y. et al. Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer. Semin. Cancer Biol. (2022).
Bandyopadhayaya, S., Ford, B. M. & Mandal, C. C. Cold-hearted: a case for cold stress in cancer risk. J. Therm. Biol. (2020).
Anderson, L. J. et al. Whole-body and adipose tissue metabolic phenotype in cancer patients. J. Cachexia Sarcopenia Muscle 13, 1124–1133 (2022).
Google Scholar
Cheng, E. et al. Adipose tissue radiodensity and mortality among patients with nonmetastatic breast cancer. Clin. Nutr. 41, 2607–2613 (2022).
Google Scholar
Di Zazzo, E., Barone, B. & Crocetto, F. Adiponcosis interplay: adipose tissue, microenvironment and prostate cancer. J. Basic Clin. Physiol. Pharm. 35, 101–103 (2024).
Google Scholar
Osisami, M. & Keller, E. T. Mechanisms of metastatic tumor dormancy. J. Clin. Med. 2, 136–150 (2013).
Google Scholar
Dumas, J.-F. & Brisson, L. Interaction between adipose tissue and cancer cells: role for cancer progression. Cancer Metastasis Rev. 40, 31–46 (2021).
Google Scholar
Choi, J., Cha, Y. J. & Koo, J. S. Adipocyte biology in breast cancer: from silent bystander to active facilitator. Prog. Lipid Res. 69, 11–20 (2018).
Google Scholar
Jain, N. et al. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood 127, 1863–1869 (2016).
Google Scholar
Si Lim, S. J., Ford, J. B. & Hermiston, M. L. How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults. Blood 141, 3019–3030 (2023).
Google Scholar
Jia, R. et al. DEX-induced SREBF1 promotes BMSCs differentiation into adipocytes to attract and protect residual T-cell acute lymphoblastic leukemia cells after chemotherapy. Adv. Sci. 10, 2205854 (2023).
Google Scholar
Mohd Ali, N. et al. Adipose MSCs suppress MCF7 and MDA-MB-231 breast cancer metastasis and EMT pathways leading to dormancy via exosomal-mirnas following co-culture interaction. Pharmaceuticals 14, (2020).
Pérez-Díaz, S. et al. The potential role of collagen type VII in breast cancer proliferation. Cancer Cell Int. 24, 254 (2024).
Google Scholar
Ritter, A. et al. Adipose tissue-derived mesenchymal stromal/stem cells, obesity and the tumor microenvironment of breast cancer. Cancers 14, 3908 (2022).
Google Scholar
Kurihara, Y. et al. Mycobacterium abscessus resides within lipid droplets and acquires a dormancy-like phenotype in adipocytes. Biochem. Biophys. Res. Commun. 758, 151645 (2025).
Google Scholar
Nyström, M. et al. Interaction of adipose-derived stem cells with active and dormant breast cancer cells. J. Plast. Reconstr. Aesthet. Surg. 83, 69–76 (2023).
Google Scholar
Ma, X., Yang, S. & Li, D. New Insights Into Adipokines and the Tumor Microenvironment in Breast Cancer. Cancer Control, 32, 10732748251347917 (2025).
Redoute-Timonnier, C. & Auguste, P. Implication of the extracellular matrix in metastatic tumor cell dormancy. Cancers, 16, 4076 (2024).
El Alaa, R. S. A. et al. Adipose-derived stromal cells and cancer-associated fibroblasts: interactions and implications in tumor progression. Int. J. Mol. Sci. 25, 11558 (2024).
Deligne, C. et al. Matrix-targeting immunotherapy controls tumor growth and spread by switching macrophage phenotype. Cancer Immunol. Res. 8, 368–382 (2020).
Popova, N. V. & Jücker, M. The functional role of extracellular matrix proteins in cancer. Cancers 14, 238 (2022).
Wang, Y. et al. The role of tenascin-C in tumor microenvironments and its potential as a therapeutic target. Front. Cell Dev. Biol. 13, 1554312 (2025).
Silvers, C. R. et al. Tenascin-C expression in the lymph node pre-metastatic niche in muscle-invasive bladder cancer. Br. J. Cancer 125, 1399–1407 (2021).
Iacono, M. L. et al. Targeting of the peritumoral adipose tissue microenvironment as an innovative antitumor therapeutic strategy. Biomolecules 12, 702 (2022).
Li, Z. et al. Omentum provides a special cell microenvironment for ovarian cancer. Cancer Rep. (Hoboken) 6, e1858 (2023).
Duarte Mendes, A. et al. Adipocyte microenvironment in ovarian cancer: a critical contributor? Int. J. Mol. Sci. 24, 16589 (2023).
Yoon, H. & Lee, S. Fatty acid metabolism in ovarian cancer: therapeutic implications. Int. J. Mol. Sci. 23, 2170 (2022).
Mukherjee, A. et al. Adipocytes reprogram cancer cell metabolism by diverting glucose towards glycerol-3-phosphate thereby promoting metastasis. Nat. Metab. 5, 1563–1577 (2023).
Lin, C. N. et al. Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer. J. Biomed. Sci. 31, 62 (2024).
Dong, Q. Premetastatic niche formation in different organs. Front. Cell Dev. Biol. (2021).
Lee, S. A. Biophysical interplay between ECM and cancer. Front. Oncol. (2024).
Patras, L. Immune determinants of the premetastatic niche. Cancer Cell (2023).
Zhang, M. & Zhang, B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp. Hematol. Oncol. 14, 54 (2025).
Google Scholar
Brock, C. K. et al. A role for adipocytes and adipose stem cells in the breast tumor microenvironment and regenerative medicine. Front. Physiol. 12, 751239 (2021).
Google Scholar
Xie, Y. et al. Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis. J. Hematol. Oncol. 15, 72 (2022).
Google Scholar
Zhang, Q. et al. Adipocyte-derived exosomal MTTP suppresses ferroptosis and promotes chemoresistance in colorectal cancer. Adv. Sci. (Weinh.) 9, 2203357 (2022).
Google Scholar
Kim, H. M., Lee, Y. K., Kim, E. S. & Koo, J. S. Energy transfer from adipocytes to cancer cells in breast cancer. Neoplasma 67, 992–1001 (2020).
Google Scholar
Micallef, P. et al. Adipose tissue-breast cancer crosstalk leads to increased tumor lipogenesis associated with enhanced tumor growth. Int. J. Mol. Sci. 22, (2021).
Cai, Z. et al. Adipocytes promote pancreatic cancer migration and invasion through fatty acid metabolic reprogramming. Oncol. Rep. 50, (2023).
Lecoutre, S. et al. Beta-hydroxybutyrate dampens adipose progenitors’ profibrotic activation through canonical Tgfβ signaling and noncanonical ZFP36-dependent mechanisms. Mol. Metab. 61, 101512 (2022).
Google Scholar
Lin, C. N., Li, W. & Wang, T. Adipocyte pyroptosis in omental metastases releases FFAs and fuels chemoresistance. J. Exp. Clin. Cancer Res. 43, 56 (2024).
Solsona-Vilarrasa, E., Fucho, R., García-Ruiz, C. & Fernández-Checa, J. C. Adipose tissue dysfunction and its role in cancer progression. Cancers 16, 1122 (2024).
Brown, K. A. Adipose tissue–tumor crosstalk: metabolic drivers of metastasis. Cancers 15, 986 (2023).
Habanjar, O., Diab-Assaf, M., Caldefie-Chezet, F. & Delort, L. Crosstalk between obesity and breast cancer: new insights on the role of adipokines. Cancers 14, 3975 (2022).
Li, Y., Xu, Q. & Ma, L. Obesity-induced inflammation and its impact on cancer progression. Int. J. Mol. Sci. 24, 2102 (2023).
Yao, L., Xu, J. & Chen, H. Systemic low-grade inflammation links obesity to cancer risk. Front. Immunol. 13, 862153 (2022).
Meier, C. & Lopez, J. NLRP3-driven systemic inflammation and tumor promotion. Int. J. Mol. Sci. 25, 2678 (2024).
Ramachandran, S. & Natarajan, R. Inflammasome activation in metabolic disease and cancer. Cancers 16, 1942 (2024).
Suzuki, Y. & Watanabe, K. Circulating adipokines and recurrence risk in cancer patients. Cancers 16, 2450 (2024).
Mendes, A. D. & Ribeiro, D. Adipocyte microenvironment in ovarian cancer. Cancers 15, 1987 (2023).
Yoon, H. & Kim, D. Fatty acid metabolism in ovarian cancer—link to metastasis and adipocyte coculture. Int. J. Mol. Sci. 23, 11789 (2022).
Google Scholar
Ramu, S. & Chandra, P. Adipose extracellular vesicles as systemic modulators of cancer. Cancers 17, 321 (2025).
Wang, Y. & Zhang, L. Extracellular vesicles from adipose tissue in tumor progression. Front. Oncol. 14, 1150 (2024).
Zhu, Y. & Guo, J. Adipose-derived stem cell exosomes reprogram breast tumor behavior. Cancers 16, 2611 (2024).
Aguilar-Cazares, D. & Chavez-Dominguez, R. Adipose tissue inflammation and immune suppression in cancer. Front. Immunol. 13, 944160 (2022).
Guria, A. & Sarkar, S. Adipose tissue macrophage plasticity in cancer-associated inflammation. Int. J. Mol. Sci. 24, 4111 (2023).
Deng, M. et al. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia. Front. Immunol. 14, 1159411 (2023).
Google Scholar
Hu, J. et al. Identification and evaluation of lipocalin-2 in sepsis-associated encephalopathy via machine learning approaches. J. Inflamm. Res. 18, 3843–3858 (2025).
Google Scholar
Zhang, H. et al. Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nanobased drug delivery systems for cancer therapy. Acta Pharm. Sin. B 14, 4717–4737 (2024).
Google Scholar
Terry, A. R. & Hay, N. Emerging targets in lipid metabolism for cancer therapy. Trends Pharm. Sci. 45, 537–551 (2024).
Google Scholar
Guerrero-Rodríguez, S. L., Mata-Cruz, C., Pérez-Tapia, S. M. & Velasco-Velázquez, M. A. Role of CD36 in cancer progression, stemness, and targeting. Front. Cell Dev. Biol. 10, 1079076 (2022).
Google Scholar
Tzeng, S.-F., et al. Clinical development of a neutralizing CD36 antibody (PLT-012) reverses lipid-fueled immune suppression and shows activity in advanced cancers. Cancer Discov. (2025).
Geppert, J. & Rohm, M. Cancer cachexia: biomarkers and the influence of age. Mol. Oncol. 18, 2070–2086 (2024).
Google Scholar
Suriben, R. et al. Antibody-mediated inhibition of GDF15–GFRAL activity reverses cancer cachexia in mice. Nat. Med. 26, 1264–1270 (2020).
Google Scholar
Li, Z. et al. Association between high body mass index and prognosis of patients with early-stage breast cancer: a systematic review and meta-analysis. Cancer Pathog. Ther. 1, 205–215 (2023).
Google Scholar
Goedeke, J. & Muensterer, O. J. The role of obesity in cancer development. IJS Oncol. 4, e77 (2019).
Google Scholar
Bhattacharya, N., Maurya, S. K., Bhattacharya, A. & Senapati, S. in Obesity and Cancer (eds Kumar, S. & Gupta, S.) 1–12 (Springer Singapore, 2021).
Amin, M. N. et al. How the association between obesity and inflammation may lead to insulin resistance and cancer. Diab. Metab. Syndr. Clin. Res. Rev. 13, 1213–1224 (2019).
Assumpção, J. A. F. et al. The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy. J. Biomed. Sci. 29, 12 (2022).
Google Scholar
Fontvieille, E. et al. Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies. BMC Med. 21, 418 (2023).
Google Scholar
Wang, W. et al. Normal weight obesity, circulating biomarkers and risk of breast cancer: a prospective cohort study and meta-analysis. Br. J. Cancer 132, 203–211 (2025).
Google Scholar
Naaman, S. C., Shen, S., Zeytinoglu, M. & Iyengar, N. M. Obesity and breast cancer risk: the oncogenic implications of metabolic dysregulation. J. Clin. Endocrinol. Metab. 107, 2154–2166 (2022).
Google Scholar
Greenlee, H. et al. Obesity-associated breast inflammation among Hispanic/Latina breast cancer patients. Cancer Prev. Res. (Philos.) 12, 21–30 (2019).
Google Scholar
Ge, Y. Z. et al. The age-related obesity paradigm: results from two large prospective cohort studies. J. Cachexia Sarcopenia Muscle 15, 442–452 (2024).
Google Scholar
Mohammed, A. Q. et al. Association of novel inflammatory and metabolic markers with mortality in individuals with overweight and obesity. Nutr. Metab. Cardiovasc. Dis. 35, 103859 (2025).
Google Scholar
Yang, Y. C. et al. Young adult risk factors for cancer: obesity, inflammation, and sociobehavioral mechanisms. Am. J. Prev. Med. 53, S21–s29 (2017).
Google Scholar
Dibaba, D. T. et al. Association between obesity and biomarkers of inflammation and metabolism with cancer mortality in a prospective cohort study. Metabolism 94, 69–76 (2019).
Google Scholar
Huang, B. Z. et al. Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk. Mol. Carcinog. 57, 1278–1288 (2018).
Google Scholar
Gholami, M. et al. Association of miRNA targetome variants in LAMC1 and GNB3 genes with colorectal cancer and obesity. Cancer Med. 11, 3923–3938 (2022).
Google Scholar
Jiang, R. et al. Association between body mass index combined with high-sensitivity C-reactive protein and the risk of postmenopausal breast cancer: a prospective cohort study. Mol. Clin. Oncol. 21, 64 (2024).
Google Scholar
Holm, J. B. et al. Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups. Sci. Rep. 14, 14486 (2024).
Google Scholar
Chang, M. C., Eslami, Z., Ennis, M. & Goodwin, P. J. Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis. NPJ Breast Cancer 7, 97 (2021).
Google Scholar
Birts, C. N. et al. Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma. Sci. Rep. 12, 7802 (2022).
Google Scholar
Maliniak, M. L. et al. Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer. Breast Cancer Res. 22, 65 (2020).
Google Scholar
Yarmolinsky, J. et al. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. EBioMedicine 100, 104991 (2024).
Google Scholar
Zwager, M. C. et al. Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients. Breast Cancer Res. Treat. 204, 27–37 (2024).
Google Scholar
Birts, C. N., Davies, C. C. & Blaydes, J. P. Crown-like structures in breast adipose tissue are associated with trastuzumab resistance and poorer prognosis in HER2-positive breast cancer. Sci. Rep. 12, 10107 (2022).
Google Scholar
Wu, C., Dong, S., Huang, R. & Chen, X. Cancer-associated adipocytes and breast cancer: intertwining in the tumor microenvironment and challenges for cancer therapy. Cancers 15, 726 (2023).
Cai, Q., Yang, J., Shen, H. & Xu, W. Cancer-associated adipocytes in the ovarian cancer microenvironment. Am. J. Cancer Res. 14, 3259–3279 (2024).
Google Scholar
Grigoraș, A. & Amalinei, C. Multi-faceted role of cancer-associated adipocytes in colorectal cancer. Biomedicines. 11, (2023).
Na, H., Song, Y. & Lee, H. W. Emphasis on adipocyte transformation: anti-inflammatory agents to prevent the development of cancer-associated adipocytes. Cancers 15, 502 (2023).
Sanhueza, S., Simón, L., Cifuentes, M. & Quest, A. F. G. The adipocyte-macrophage relationship in cancer: a potential target for antioxidant therapy. Antioxidants. 12, (2023).
Yang, Z. et al. Dissecting the emerging role of cancer-associated adipocyte-derived cytokines in remodeling breast cancer progression. Heliyon 10, e35200 (2024).
Google Scholar
Huang, H. et al. Cellular succinate metabolism and signaling in inflammation. Signal Transduct. Target. Ther. 9, 78 (2024).
Li, Z. et al. Targeting the lactic acid metabolic pathway for antitumor therapy. Signal Transduct. Target. Ther. 8, 391 (2023).
Google Scholar
Zhang, W. & Lang, R. Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer. Front. Cell Dev. Biol. 11, 1266973 (2023).
Google Scholar
Ghosh, R. et al. Targeting HIF-1α by natural and synthetic compounds. Biomedicines. 10, (2022).
Griffin, M. J. & Ryu, S. On the immunometabolic role of NF-κB in adipocytes. Int. J. Mol. Sci. 23, (2022).
McKernan, K. et al. Role of TLR4 in the induction of inflammatory changes in adipocytes and macrophages. Adipocyte 9, 212–222 (2020).
Google Scholar
Dou, H. X. et al. Exogenous FABP4 induces p38/HSL-mediated lipolysis and p38/NF-κB-mediated inflammation. Life Sci. 254, 117800 (2020).
Jiang, C. et al. Small extracellular vesicle-mediated metabolic reprogramming. Cell Death Discov. 9, 383 (2023).
Leiva, M. et al. Unraveling the role of p38 family members in adipose tissue. Int. J. Mol. Sci. 21, 8261 (2020).
Qin, C. et al. The systematic role of pancreatic cancer exosomes. Front. Oncol. 14, 1305939 (2024).
Fontana, F. et al. The PI3K/Akt pathway and glucose metabolism. Int. J. Mol. Sci. 25, (2024).
Yang, L. CD36-mediated metabolic crosstalk between tumor and immune cells in liver cancer. Nat. Commun. 13, 5782 (2022).
Google Scholar
Jurj, A., Paul, D. & Calin, G. A. Extracellular vesicles in cancer: from isolation and characterization to metastasis, drug resistance, and clinical applications. BMC Cancer 25, 1154 (2025).
Google Scholar
Ramos, C. C. et al. Extracellular vesicles in tumor-adipose tissue crosstalk: key drivers and therapeutic targets in cancer cachexia. Extracell. Vesicles Circ. Nucl. Acids 5, 371–396 (2024).
Google Scholar
Neira, G. et al. Increased expression of IL-1β in adipose tissue in obesity influences the development of colon cancer by promoting inflammation. J. Physiol. Biochem 81, 471–482 (2025).
Google Scholar
Maliniak, M. L. et al. Crown-like structures in breast adipose tissue: early evidence and current issues in breast cancer. Cancers. 13, (2021).
Randall, T. D. & Meza-Perez, S. Immunity in adipose tissues: cutting through the fat. Immunol. Rev. 324, 4–10 (2024).
Google Scholar
Liu, T. et al. ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis. Clin. Immunol. 254, 109698 (2023).
Google Scholar
Wu, Y. et al. FAP expression in adipose tissue macrophages promotes obesity and metabolic inflammation. Proc. Natl. Acad. Sci. USA 120, e2303075120 (2023).
Google Scholar
Sprenkle, N. T. et al. The miR-23-27-24 clusters drive lipid-associated macrophage proliferation in obese adipose tissue. Cell Rep. 42, 112928 (2023).
Google Scholar
Oussaada, S. M. et al. Tissue-specific inflammation and insulin sensitivity in subjects with obesity. Diab. Res Clin. Pr. 211, 111663 (2024).
Google Scholar
Tarantino, G. Gut microbiome, obesity-related comorbidities, and low-grade chronic inflammation. J. Clin. Endocrinol. Metab. 99, 2343–2346 (2014).
Google Scholar
Lu, X. et al. UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders. Cell Metab. 35, 1390–1405.e1398 (2023).
Google Scholar
Wu, R. et al. Intratumoral tumor infiltrating lymphocytes (TILs) are associated with cell proliferation and better survival however, not always with chemotherapy response in breast cancer. Ann. Surg. 278, 587–597 (2023).
Google Scholar
Wang, X. et al. Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development. Immunity 56, 58–77.e11 (2023).
Google Scholar
Liao, X. et al. Adipose stem cells control obesity-induced T-cell infiltration into adipose tissue. Cell Rep. 43, 113963 (2024).
Google Scholar
Reinisch, I. et al. Adipocyte p53 coordinates the response to intermittent fasting by regulating adipose tissue immune cell landscape. Nat. Commun. 15, 1391 (2024).
Google Scholar
Kolb, R. et al. Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4. Oncogene 38, 2351–2363 (2019).
Google Scholar
Incio, J. et al. Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy. Cancer Discov. 6, 852–869 (2016).
Google Scholar
Moukarzel, L. A. et al. Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancer. Cancer 128, 3297–3309 (2022).
Google Scholar
Lee, J. H., Hyung, S., Lee, J. & Choi, S. H. Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study. J. Immunother. Cancer. 10, e005226 (2022).
Mirsoian, A. & Murphy, W. J. Obesity and cancer immunotherapy toxicity. Immunotherapy 7, 319–322 (2015).
Google Scholar
Pasupuleti, S. K. et al. Obesity-induced inflammation exacerbates clonal hematopoiesis. J. Clin. Invest. 133, (2023).
Doyle, S. L., Donohoe, C. L., Lysaght, J. & Reynolds, J. V. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc. Nutr. Soc. 71, 181–189 (2012).
Google Scholar
Lam, T. K. et al. Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers. J. Natl. Cancer Inst. 116, 1555–1561 (2024).
Google Scholar
Zhang, A. M. Y. et al. Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Cell Metab. 35, 2119–2135.e2115 (2023).
Google Scholar
Li, W. et al. Insulin resistance and inflammation mediate the association of abdominal obesity with colorectal cancer risk. Front. Endocrinol. 13, 983160 (2022).
Google Scholar
Fang, H. et al. Adipocytokines and inflammation in patients and a gerbil model: implications for obesity-related and nonobese diabetes. J. Diab. Res. 2024, 9683512 (2024).
Google Scholar
Hateley, C. et al. Multitissue profiling of oxylipins reveal a conserved upregulation of epoxide:diol ratio that associates with white adipose tissue inflammation and liver steatosis in obesity. EBioMedicine 103, 105127 (2024).
Google Scholar
Maqdasy, S. et al. Impaired phosphocreatine metabolism in white adipocytes promotes inflammation. Nat. Metab. 4, 190–202 (2022).
Google Scholar
Belda, E. et al. Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism. Gut 71, 2463–2480 (2022).
Google Scholar
Sánchez-Alcoholado, L. et al. Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer. Int. J. Mol. Sci. 21, (2020).
Kang, X. et al. Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice. EBioMedicine 93, 104670 (2023).
Google Scholar
Shao, X. et al. High-fat diet promotes colitis-associated tumorigenesis by altering gut microbial butyrate metabolism. Int. J. Biol. Sci. 19, 5004–5019 (2023).
Google Scholar
Madka, V. et al. Targeting IL-23 for the interception of obesity-associated colorectal cancer. Neoplasia 45, 100939 (2023).
Google Scholar
Parida, S. et al. Gut colonization with an obesity-associated enteropathogenic microbe modulates the premetastatic niches to promote breast cancer lung and liver metastasis. Front. Immunol. 14, 1194931 (2023).
Google Scholar
Zhang, X. et al. Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial. EBioMedicine 98, 104873 (2023).
Google Scholar
Liu, K. et al. Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome. Clin. Epigenet. 15, 86 (2023).
Google Scholar
Pita-Grisanti, V. et al. Physical activity decreases inflammation and delays the development of obesity-associated pancreatic ductal adenocarcinoma. Cancer Res. 84, 3058–3071 (2024).
Google Scholar
Lohman, M. C. et al. Obesity, dietary inflammation, and frailty among older adults: evidence from the National Health and Nutrition Examination Survey. J. Nutr. Gerontol. Geriatr. 38, 18–32 (2019).
Google Scholar
Shafiee, N. H. et al. Dietary Inflammatory Index, obesity, and the incidence of colorectal cancer: findings from a hospital-based case‒control study in Malaysia. Nutrients 15, (2023).
Son, D. S. et al. Intermittent fasting attenuates obesity-induced triple-negative breast cancer progression by disrupting cell cycle, epithelial–mesenchymal transition, immune contexture, and proinflammatory signature. Nutrients 16, (2024).
Zhou, C. et al. Fenugreek attenuates obesity-induced inflammation and improves insulin resistance through downregulation of iRhom2/TACE. Life Sci. 258, 118222 (2020).
Google Scholar
Li, Y. et al. Rabeprazole mitigates obesity-induced chronic inflammation and insulin resistance associated with increased M2-type macrophage polarization. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 167142 (2024).
Google Scholar
Yang, J. et al. FABP4 in macrophages facilitates obesity-associated pancreatic cancer progression via the NLRP3/IL-1β axis. Cancer Lett. 575, 216403 (2023).
Google Scholar
Goldbaum, A. A. et al. The role of diet and the gut microbiota in the obesity-colorectal cancer link. Nutr. Cancer 77, 626–639 (2025).
Google Scholar
Wang, J. Y. et al. GLP-1 receptor agonists for the treatment of obesity: role as a promising approach Front. Endocrinol. 14, 1085799 (2023).
Szekeres, Z., Nagy, A., Jahner, K. & Szabados, E. Impact of selected glucagon-like peptide-1 receptor agonists on serum lipids, adipose tissue, and muscle metabolism—a narrative review. Int. J. Mol. Sci. 25, 8214 (2024).
Levy, S. et al. Differential effects of GLP-1 receptor agonists on cancer risk in obesity: a nationwide analysis of 1.1 million patients. Cancers 17, 78 (2025).
Mehdi, S. F. et al. GLP-1 as a multifaceted anti-inflammatory mediator: implications for adipose macrophage biology. Front. Immunol. (2023).
Borlaug, B. A. et al. Effects of tirzepatide on systemic inflammation and end-organ metrics. Nat. Med. (2024).
Yuneva, M. Cold exposure as anticancer therapy. Cancer Cell (2022).
Long, R. et al. Antibody‒drug conjugates in cancer therapy: applications and future advances. Front. Immunol. (2025).
Sakai, J. β-adrenergic signaling regulates a concerted thermogenic response in brown adipose tissue and white adipose tissue. Brain Nerve (2022).
Valdívia, L. F. G. et al. Cold acclimation and pioglitazone combined increase thermogenic capacity of BAT and WAT but this does not translate into higher energy expenditure. Am. J. Physiol. Endocrinol. Metab. (2023).
Straat, M. E. et al. Cold exposure induces dynamic changes in circulating triacylglycerol species, which is dependent on intracellular lipolysis: A randomized crossover trial. EBioMedicine 86, 104349 (2022).
Google Scholar
Shams, S. et al. Effects of swimming in cold water on lipolysis indicators via fibroblast growth factor-21 in male Wistar rats. Biochem. Biophys. Rep. 38, 101662 (2024).
Google Scholar
Voskarides, K. The double face of cold in cancer. Transl. Oncol. (2022).
Spiljar, M. et al. Cold exposure protects from neuroinflammation through immunologic reprogramming. Cell Metab. (2021).
Sharav’eva, I. L. & Gein, S. V. Influence of acute cold stress on the secretion of IL-2, IL-4, IFNγ, IL-12 in vivo by mouse splenocytes. Med. Immunol. (2022).
Grazioso, T. P. & Djouder, N. A mechanistic view of the use of cold temperature in the treatment of cancer. iScience (2023).
Kim, W., et al. NG-497, a potent and selective small-molecule ATGL inhibitor, modulates lipid metabolism in human systems. Endocrinology 166, (2025).
Rossi, M. et al. Bromodomain and extraterminal inhibitors potentiate adipose triglyceride lipase-mediated lipolysis to suppress tumor growth. J. Exp. Clin. Cancer Res. 42, 22 (2023).
Schweiger, M. et al. Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice. Nat. Commun. 8, 14859 (2017).
Google Scholar
Wang, S., Wu, S. & Peng, D. Dilated cardiomyopathy caused by mutation of the PNPLA2 gene: a case report and literature review. Front. Genet. 15, 1415156 (2024).
Google Scholar
Hakim, N., Patel, R., DeVoe, C. & Saif, M. W. Why HALO 301 Failed and Implications for Treatment of Pancreatic Cancer. Expert Rev. Anticancer Ther. 19, 999–1001 (2019).
Van Cutsem, E. et al. Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma. J. Clin. Oncol. 38, 3185–3194 (2020).
Google Scholar
Järveläinen, H. A. et al. Assessment of the pharmacokinetics, disposition and duration of action of the tumor-targeting peptide CEND-1 (iRGD). Br. J. Clin. Pharmacol. 89, 3117–3132 (2023).
ClinicalTrials.gov. CEND-1 in combination with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma (CENDIFOX). (2018).
Dean, A. et al. Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine in metastatic pancreatic cancer: a phase 1 study. Br. J. Cancer 127, 1898–1907 (2022).
Ernesto, C. S. et al. LCN2 blockade mitigating metabolic dysregulation and redefining appetite control in type 2 diabetes. Metab. Brain Dis. 40, 97 (2025).
Google Scholar
Fougerat, A. et al. ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity. Cell Rep. 39, 110910 (2022).
Google Scholar
Mouisel, E. et al. Cold-induced thermogenesis requires neutral-lipase-mediated intracellular lipolysis in brown adipocytes. Cell Metab. 37, 429–440.e425 (2025).
Google Scholar
Awad, D. et al. Adipose triglyceride lipase is a therapeutic target in advanced prostate cancer that promotes metabolic plasticity. Cancer Res 84, 703–724 (2024).
Google Scholar
Hakim, N., Patel, R., DeVoe, C. & Saif, M. W. Why HALO 301 failed and implications for the treatment of pancreatic cancer. Expert Rev. Anticancer Ther. 19, 999–1001 (2019).
Van Cutsem, E. et al. Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma (HALO 301). J. Clin. Oncol. 38, 3185–3194 (2020).
Google Scholar
Dean, A. et al. Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine in metastatic pancreatic cancer: a phase 1 study. Gastroenterol. Hepatol. 7, 943–951 (2022).
Google Scholar
Pan, Y. et al. Glycoengineering-based anti-PD-1–iRGD peptide conjugate boosts antitumor efficacy through T-cell engagement. Cell Rep. Med. 5, 101590 (2024).
Google Scholar
Argentiero, A. et al. Decoding the intricate landscape of pancreatic cancer: insights into tumor biology, microenvironment, and therapeutic interventions. Cancers 16, 2438 (2024).
Google Scholar
Mehraj, U. et al. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: new challenges and therapeutic opportunities. Cell Oncol. Dordr. 44, 1209–1229 (2021).
Google Scholar
Gupta, M. K., Gouda, G. & Vadde, R. Role of the tumor microenvironment in mediating resistance to anti-HER2 antibodies. Crit. Rev. Oncog. 29, 43–54 (2024).
Google Scholar
Wang, T. et al. Cancer-associated adipocytes promote breast cancer progression through metabolic reprogramming. Nat. Commun. 11, 4976 (2020).
Google Scholar
Dirat, B. et al. Cancer-associated adipocytes: key players in breast cancer progression. Cancer Res. 71, 2455–2465 (2011).
Google Scholar
Zhuang, X., Zhang, H. & Hu, G. Phenotypic and functional diversity of cancer-associated adipocytes in the tumor microenvironment. Front. Oncol. 12, 824316 (2022).
Tan, Y. et al. Cancer-associated adipocyte-derived cytokines orchestrate breast cancer invasion and immune evasion. Cell Rep. Med. 4, 100970 (2023).
Wu, Q. et al. FABP4 as a mediator of tumor–adipocyte metabolic crosstalk. Cancer Res. 79, 4441–4455 (2019).
Sun, K., Kusminski, C. M. & Scherer, P. E. Single-cell dissection of adipocyte heterogeneity in the tumor niche. Nat. Metab. 2, 97–109 (2020).
Google Scholar
Zhang, M. et al. Lineage tracing reveals adipocyte-to-fibroblast transition in the tumor microenvironment. Cell Metab. 33, 917–932 (2021).
Liu, W. et al. JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte-derived leptin. Cancer Commun. 43, 1117–1142 (2023).
Google Scholar
Naimo, G. D. et al. Adiponectin influences the behavior of stem cells in hormone-resistant breast cancer. Cells. 14, (2025).
Zhang, M. et al. Adipocyte-derived lipids mediate melanoma progression via FATP proteins. Cancer Discov. 8, 1006–1025 (2018).
Google Scholar
Zhang, P. et al. Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment. Cell Metab. 34, 1359–1376.e1357 (2022).
Google Scholar
Michel, L. Y. M. Extracellular vesicles in adipose tissue communication with the healthy and pathological heart. Int. J. Mol. Sci. 24, 7745 (2023).
Google Scholar
Camino, T., Lago-Baameiro, N. & Pardo, M. Extracellular vesicles as carriers of adipokines and their role in obesity. Biomedicines 11, 422 (2023).
Google Scholar
Munteanu, R. et al. Adipocyte-based cell therapy in oncology: the role of cancer-associated adipocytes and their reinterpretation as delivery platforms. Pharmaceutics 12, 402 (2020).
Google Scholar
Kumar, A. et al. High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance. Nat. Commun. 12, 213 (2021).
Google Scholar
Melo, S. A. et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523, 177–182 (2015).
Google Scholar
Zhang, C. et al. Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts. Cell Death Dis. 13, 57 (2022).
Google Scholar
Ippolito, L. et al. Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer. Cancer Res. 82, 1267–1282 (2022).
Google Scholar
Minami, J. K. et al. CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. Cancer Cell 41, 1048–1060.e1049 (2023).
Google Scholar
Wang, G. et al. Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis. Sci. Transl. Med. 14, eabk2756 (2022).
Google Scholar
Jin, X. et al. A metastasis map of human cancer cell lines. Nature 588, 331–336 (2020).
Google Scholar
Liu, W. et al. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat. Commun. 12, 5103 (2021).
Google Scholar
Sawada, M. I., GD, S. F. & Passarelli, M. Cholesterol derivatives and breast cancer: oxysterols driving tumor growth and metastasis. Biomark. Med. 14, 1299–1302 (2020).
Google Scholar
Deng, C. M. et al. ANO1 reprograms cholesterol metabolism and the tumor microenvironment to promote cancer metastasis. Cancer Res. 83, 1851–1865 (2023).
Google Scholar
Goossens, P. et al. Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression. Cell Metab. 29, 1376–1389.e1374 (2019).
Google Scholar
Xie, S. et al. Single-cell transcriptome analysis reveals heterogeneity and convergence of the tumor microenvironment in colorectal cancer. Front. Immunol. 13, 1003419 (2022).
Google Scholar
Zaidi, N. et al. Dietary palmitic acid enhances metastatic potential via CD36. Cancer Res. 82, 1234 (2022).
Zhou, W. et al. CD36-mediated lipid uptake promotes metastasis-initiating cells in cancer. Nat. Commun. 15, 221 (2024).
Google Scholar
Feng, W. et al. FABP4 links adipocyte lipolysis to tumor fatty acid oxidation. Oncogene 42, 4511 (2023).
Guerrero-Rodríguez, A. et al. CD36 and FABP cooperation in adipocyte–tumor metabolic coupling. Cell Metab. 34, 2312 (2022).
Liu, Y. et al. Exosomal regulation of ferroptosis in tumor–adipocyte crosstalk. Front. Oncol. 14, 1123 (2024).
Google Scholar
Tang, Y. et al. PGC1α/CEBPB/CPT1A axis sustains FAO-mediated chemoresistance. Cancer Lett. 539, 215 (2022).
Lo Iacono, M. et al. Targeting of the peritumoral adipose tissue microenvironment as an innovative antitumor therapeutic strategy. Biomolecules. 12, (2022).
Di Rocco, G., Trivisonno, A., Trivisonno, G. & Toietta, G. Dissecting human adipose tissue heterogeneity using single-cell omics technologies. Stem Cell Res. Ther. 15, 322 (2024).
Google Scholar
Ma, L. et al. CPT1A-driven fatty acid oxidation underlies radioresistance in cancer cells. Nat. Metab. 6, 455 (2024).
Nandi, A. et al. Targeting fatty acid oxidation improves HER2+ breast cancer therapy response. Clin. Cancer Res. 30, 1189 (2024).
Yin, H. et al. Adipocyte-derived exosomes remodel lipid metabolism by upregulating SCD1. Oncogene 40, 2135 (2021).
Luis, G. et al. Stearoyl-CoA desaturase 1 regulates ferroptosis sensitivity in cancer. Cell Rep. 34, 108718 (2021).
Luo, M. et al. SCD1-mediated MUFA biosynthesis confers ferroptosis resistance. Nat. Commun. 13, 174 (2022).
Google Scholar
Wu, J. et al. Adipocyte exosome cargo protects tumor cells from lipid peroxidation. Mol. Cancer 23, 45 (2024).
Google Scholar
Pallegar, N. K. & Christian, S. L. in Tumor Microenvironment: Non-Hematopoietic Cells (ed. Alexander Birbrair) 1–13 (Springer International Publishing, 2020)
Conner, S. J. et al. Obesity induces temporally regulated alterations in the extracellular matrix that drive breast tumor invasion and metastasis. Cancer Res. 84, 2761–2775 (2024).
Google Scholar
Curran, C. S. & Ponik, S. M. The mammary tumor microenvironment. Adv. Exp. Med. Biol. 1296, 163–181 (2020).
Google Scholar
Jiramongkol, Y. & Lam, E. W. F. in Tumor Microenvironment: The Main Driver of Metabolic Adaptation (ed. Serpa, J.) 125–142 (Springer International Publishing, 2020)
Jia, N. et al. Membrane fusion liposomes deliver antifibrotic and chemotherapeutic drugs sequentially to enhance tumor treatment efficacy by reshaping tumor microenvironment. Adv. Health. Mater. 13, e2400219 (2024).
Google Scholar
Yao, Y. et al. Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multidimensional treatment of ovarian cancer. J. Nanobiotechnol. 23, 83 (2025).
Google Scholar
Li, Y. et al. Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation. Environ. Res. 239, 117266 (2023).
Google Scholar
Siqueira, I. R. et al. Circulating extracellular vesicles and particles derived from adipocytes: the potential role in spreading MicroRNAs associated with cellular senescence. Front. Aging 3, 867100 (2022).
Google Scholar
Williams, M. E. et al. Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer. Cell Commun. Signal 22, 443 (2024).
Google Scholar
Zhao, D. et al. Exosomal miR-1304-3p promotes breast cancer progression in African Americans by activating cancer-associated adipocytes. Nat. Commun. 13, 7734 (2022).
Google Scholar
Pham, D.-V. & Park, P.-H. Tumor metabolic reprogramming by adipokines as a critical driver of obesity-associated cancer progression. Int. J. Mol. Sci. 22, 1444 (2021).
Google Scholar
Maurya, S. K., Bhattacharya, N., Bhattacharya, A. & Senapati, S. in Obesity and Cancer (eds Kumar, S. & Gupta, S.) 49–79 (Springer Singapore, 2021).
Chen, J. et al. A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation. Proc. Natl. Acad. Sci. USA 121, e2306776121 (2024).
Google Scholar
Sun, B. et al. FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. Redox Biol. 75, 103302 (2024).
Google Scholar
An, C. et al. The molecular link between obesity and genomic instability in cancer development. Cancer Lett. 555, 216035 (2023).
Google Scholar
Ray, A. & Acharya, D. in Functional Foods in Cancer Prevention and Therapy (ed. Kabir, Y.) 73–98 (Academic Press, 2020).
Cai, L. et al. Adiponectin induces CXCL1 secretion from cancer cells and promotes tumor angiogenesis by inducing stromal fibroblast senescence. Mol. Carcinog. 55, 1796–1806 (2016).
Google Scholar
Ouh, Y. T. et al. CXC chemokine ligand 1 mediates adiponectin-induced angiogenesis in ovarian cancer. Tumor Biol. 42, 1010428319842699 (2019).
Google Scholar
Kiezun, M. et al. Adiponectin expression in the porcine pituitary during the estrous cycle and its effect on LH and FSH secretion. Am. J. Physiol. Endocrinol. Metab. 307, E1038–E1046 (2014).
Google Scholar
Li, C. et al. Adiponectin inhibits the progression of obesity-associated papillary thyroid carcinoma through autophagy. Endocrinology 165, (2024).
Michalakis, K. et al. In prostate cancer, low adiponectin levels are not associated with insulin resistance. Eur. J. Clin. Invest 45, 572–578 (2015).
Google Scholar
Xiao, H. et al. Adiponectin deficiency prevents chronic colitis-associated colonic fibrosis by inhibiting CXCL13 production. J. Adv. Res. (2024).
Park, K. B. et al. Leptin stimulates migration and invasion and maintains cancer stem‑like properties in gastric cancer cells. Oncol. Rep. 48, 162 (2022).
Google Scholar
Li, Z. et al. A novel peptide protects against diet-induced obesity by suppressing appetite and modulating the gut microbiota. Gut 72, 686–698 (2023).
Google Scholar
Elsayed, E. Y., Mosalam, N. A. & Mohamed, N. R. Resistin and insulin resistance: a link between inflammation and hepatocarcinogenesis. Asian Pac. J. Cancer Prev. 16, 7139–7142 (2015).
Google Scholar
Rzepa et al. Resistin is associated with inflammation and renal function, but not with insulin resistance in type 2 diabetes. Horm. Metab. Res. 53, 478–484 (2021).
Google Scholar
Yang, H. M. et al. Resistin regulates inflammation and insulin resistance in humans via the endocannabinoid system. Research 7, 0326 (2024).
Google Scholar
Chen, M. et al. Association of plasma visfatin with risk of colorectal cancer: an observational study of Chinese patients. Asia Pac. J. Clin. Oncol. 12, e65–e74 (2016).
Google Scholar
Zhao, J. et al. An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer. Biochem. Biophys. Res. Commun. 718, 149931 (2024).
Google Scholar
Zhao, Q. et al. Visfatin inhibits colon cancer apoptosis and decreases chemosensitivity to 5‑FU by promoting the SDF‑1/CXCR4/Akt axis. Int. J. Oncol. 60, (2022).
Martinerie, C. et al. NOV/CCN3: a new adipocytokine involved in obesity-associated insulin resistance. Diabetes 65, 2502–2515 (2016).
Google Scholar
Liang, T. et al. NOV/CCN3 promotes cell migration and invasion in intrahepatic cholangiocarcinoma via miR-92a-3p. Genes 12, (2021).
Tahergorabi, Z. et al. Crosstalk between obesity and cancer: a role for adipokines. Arch. Physiol. Biochem. 130, 155–168 (2024).
Google Scholar
Liu, Z. et al. Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression. OncoImmunology 11, 2085432 (2022).
Google Scholar
Wen, D. et al. Adipocytes encapsulating telratolimod recruit and polarize tumor-associated macrophages for cancer immunotherapy. Adv. Sci. 10, 2206001 (2023).
Google Scholar
Li, J. & Xu, R. Obesity-Associated ECM Remodeling in Cancer Progression. Cancers 14, 5684 (2022).
Google Scholar
Yuan, Z. et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol. Cancer 22, 48 (2023).
Google Scholar
Cui, X. et al. RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling by enhancing FOSL2 transcriptional activation in glioblastoma. Cell Death Dis. 15, 98 (2024).
Google Scholar
Famili-Youth, E. H. H. et al. Aberrant expression of collagen type X in solid tumor stroma is associated with EMT, immunosuppressive and pro-metastatic pathways, bone marrow stromal cell signatures, and poor survival prognosis. BMC Cancer 25, 247 (2025).
Google Scholar
Jo, Y. et al. Machine learning-featured Secretogranin V is a circulating diagnostic biomarker for pancreatic adenocarcinomas associated with adipopenia. Front. Oncol. 12, 942774 (2022).
Google Scholar
Kilpatrick, S. E. Atypical lipomatous tumor/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated?. Hum. Pathol. 147, 82–91 (2024).
Google Scholar
Grochowski, P. et al. The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma. BMC Cancer 24, 768 (2024).
Google Scholar
Grosser, B. et al. Stroma AReactive Invasion Front Areas (SARIFA) – a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes. J. Pathol. 256, 71–82 (2022).
Google Scholar
Shang, J. R. et al. Adipocytes impact on gastric cancer progression: prognostic insights and molecular features. World J. Gastrointest. Oncol. 16, 3011–3031 (2024).
Google Scholar
Lee, J. W. et al. Clinical significance of peritumoral adipose tissue PET/CT imaging features for predicting axillary lymph node metastasis in patients with breast cancer. J. Pers. Med. 11, (2021).
Qi, Y. J. et al. Radiomics in breast cancer: current advances and future directions. Cell Rep. Med. 5, 101719 (2024).
Google Scholar
Lee, J. W. et al. Peritumoral adipose tissue features derived from [(18)F]fluoro-2-deoxy-2-d-glucose positron emission tomography/computed tomography as predictors for response to neoadjuvant chemotherapy in breast cancer patients. J. Pers. Med. 14, (2024).
Wang, J. & Pan, W. The biological role of the collagen alpha-3 (VI) chain and its cleaved C5 domain fragment endotrophin in cancer. Onco Targets Ther. 13, 5779–5793 (2020).
Google Scholar
Zhang, W. et al. The potential of secretogranin V as a prognostic biomarker in non-small cell lung cancer. Sci. Rep. 15, 16589 (2025).
Google Scholar
Li, B. et al. Macrophages in tumor-associated adipose microenvironment accelerate tumor progression. Adv. Biol. 7, e2200161 (2023).
Google Scholar
Moorman, H. R. et al. Osteopontin: a key regulator of tumor progression and immunomodulation. Cancers. 12, (2020).
Gu, Y. et al. Osteopontin is a therapeutic target that drives breast cancer recurrence. Nat. Commun. 15, 9174 (2024).
Google Scholar
Wang, Q., Wang, Y. & Xu, D. The roles of T cells in obese adipose tissue inflammation. Adipocyte 10, 435–445 (2021).
Google Scholar
Hernández-García, E. et al. Conventional type 1 dendritic cells protect against age-related adipose tissue dysfunction and obesity. Cell. Mol. Immunol. 19, 260–275 (2022).
Google Scholar
Brombacher, E. C. & Everts, B. Shaping of dendritic cell function by the metabolic micro-environment. Front. Endocrinol. 11, (2020).
Merkley, E. D. et al. The succinated proteome. Mass Spectrom. Rev. 33, 98–109 (2014).
Google Scholar
Ma, Q. et al. Governing glutaminolysis by regulation of glutaminase succinylation. Protein Cell 13, 163–166 (2022).
Google Scholar
Teng, P. et al. SIRT5-mediated ME2 desuccinylation promotes cancer growth by enhancing mitochondrial respiration. Cell Death Differ 31, 65–77 (2024).
Google Scholar
Yang, H. et al. SIRT5-mediated GLS and GDH desuccinylation attenuates the autophagy of bovine mammary epithelial cells induced by ammonia. Cell Signal. 127, 111570 (2025).
Kwon, O. K. et al. LDHA desuccinylase Sirtuin 5 as a novel cancer metastatic stimulator in aggressive prostate cancer. Genom. Proteom. Bioinform 21, 177–189 (2023).
Google Scholar
Shi, L. et al. LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer. Cell Death Differ. 30, 1517–1532 (2023).
Google Scholar
Adejor, J. et al. Impact of lysine succinylation on the biology of fungi. Curr. Issues Mol. Biol. 46, 1020–1046 (2024).
Albakova, Z. et al. HSP90 multi-functionality in cancer. Front. Immunol. 15, 1436973 (2024).
Backe, S. J., Sager, R. A., Woodford, M. R., Makedon, A. M. & Mollapour, M. Post-translational modifications of Hsp90 and translating the chaperone code. J. Biol. Chem. 295, 11099–11117 (2020).
Han, Y. et al. KAT2A-promoted succinylation of Sp1 activates mTOR. J. Transl. Med. 22, 427 (2024).
Google Scholar
Lu, K. et al. A review of the mechanism of succinylation in cancer. Cell Death Discov. 8, 457 (2022).
Shahidian, L. Z. et al. Succinylation of H3K122 destabilizes nucleosomes and enhances transcription. EMBO Rep. 22, e51009 (2021).
Google Scholar
Yang, G. et al. Histone acetyltransferase 1 is a succinyltransferase for histones and non-histones and promotes tumorigenesis. EMBO Rep. 22, e50967 (2021).
Google Scholar
Ibrahim, L. et al. Succinylation of a KEAP1 sensor lysine promotes NRF2. Nat. Commun. 14, 5320 (2023).
Google Scholar
Kührer, N. et al. Targeting metabolic and epigenetic reprogramming in FH-deficient tumors. Br. J. Cancer. 133, (2025).
Song, Y. et al. Post translational modifications of Keap1: the state of the art. Front. Cell Dev. Biol. 12, 1332049 (2024).
Google Scholar
Hou, X. et al. Dysregulation of protein succinylation and disease development. Front. Mol. Biosci. 11 (2024).
Gao, J. & Yu, W. Regulators of cancer progression: succinylation. Cancers 17, 2652 (2025).
Google Scholar
Seo, J. H. et al. Deconvoluting complex tissues for expression quantitative trait locus-based analyses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368, 20120363 (2013).
Google Scholar
Liu, Y., Gusev, A. & Kraft, P. Germline cancer gene expression quantitative trait loci are associated with local and global tumor mutations. Cancer Res. 83, 1191–1202 (2023).
Google Scholar
Lv, F. et al. eQTL and multiomics integration reveal PPIH as a prognostic and immunotherapeutic biomarker. Front. Immunol. 16, (2025).
Koru-Sengul, T. et al. Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to nonblack Latinas and Caucasians. Breast Cancer Res. Treat. 158, 113–126 (2016).
Google Scholar
Liu, B. et al. Prevalence and patterns of breast white adipose tissue inflammation among American Black women and indigenous Nigerian women with early-stage breast cancer. J. Clin. Oncol. 41, e12560 (2023).
Google Scholar
Liadis, N. et al. Using a multimodal approach to elucidate racial disparities in breast cancer biology by integrating tumor imaging and -omics data. J. Clin. Oncol. 40, e12541 (2022).
Google Scholar
Marczyk, M. et al. Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer. NPJ Breast Cancer (2022).
Yang, Y. Editorial: The adipose tissue microenvironment in cancer: molecular mechanisms and targets for treatment. Front. Cell Dev. Biol. (2022).
Tahergorabi, Z. et al. Crosstalk between obesity and cancer: a role for adipokines. Arch. Physiol. Biochem. (2021).
Sanhueza, S., Vergara, P. & Leyton, L. The adipocyte–macrophage relationship in Cancer. Int. J. Mol. Sci. (2023).
Yang, Z., Liu, Y. & Zhang, X. Dissecting the emerging role of cancer-associated adipocyte-derived cytokines in remodeling breast cancer progression. Front. Oncol. (2024).
Gu, Y., Zhou, H. & Li, X. Osteopontin is a therapeutic target that drives breast cancer recurrence by recruiting and polarizing macrophages. Nat. Commun. (2024).
Tang, Y., Zhang, S. & Li, J. Regulation of CD8+ T cells by lipid metabolism in cancer progression and therapy. Cell. Mol. Immunol. (2024).
Xu, S., Cha, M. & Li, X. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity (2021).
Mantovani, A., Marchesi, F. & Allavena, P. Macrophage diversity in cancer dissemination and metastasis. Cell. Mol. Immunol. (2024).
Sun, M., Zhang, Y. & Wang, P. ALKBH5-mediated upregulation of CPT1A promotes fatty acid oxidation and M2 polarization of macrophages in colorectal cancer. Exp. Cell Res. (2024).
Jiang, C., Zhou, B. & Liu, W. Small extracellular vesicle–mediated metabolic reprogramming in the tumor microenvironment. Cell Death Discov. (2023).
Chen, M. Y., Zhang, Q. & Wang, H. Dendritic cell subsets and implications for cancer immunotherapy. Front. Immunol., (2024).
Duong, L. K., Gao, J. & Hsu, B. Lipid metabolism in tumor immunology and immunotherapy. Front. Oncol. (2023).
Wang, Y. Y. et al. Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells. JCI Insight 2, e87489 (2017).
Google Scholar
Thakir, T. M. et al. Cancer therapy and cachexia. J. Clin. Invest. 135, (2025).
Ma, Y. & Cao, H. ‘Lnc-ing’ T(reg) cells to the aging liver. Nat. Aging 3, 760–761 (2023).
Google Scholar
Falchook, G. S. et al. First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors. EClinicalMedicine 34, 100797 (2021).
Google Scholar
Kelly, W. et al. Phase II investigation of TVB-2640 (denifanstat) with bevacizumab in patients with first relapse high-grade astrocytoma. Clin. Cancer Res. 29, 2419–2425 (2023).
Google Scholar
Serhan, H. A. et al. Targeting fatty acid synthase in preclinical models of TNBC brain metastases synergizes with SN-38 and impairs invasion. NPJ Breast Cancer 10, 43 (2024).
Google Scholar
